Bipartisan Senate bargainers have agreed to a slimmed-down $10 billion package for countering COVID-19, but without any funds to help nations abroad combat the pandemic, Democrats and Republicans familiar with the talks said Monday.
At least half the measure would have to be used to research and produce therapeutics to treat the disease, according to a fact sheet distributed by the chief GOP bargainer, Sen. Mitt Romney of Utah. And at least $750 million would be used to research new COVID-19 variants and to expand vaccine production, the description said.
